US 11,717,013 B1
Micronutrient combination to reduce blood pressure
Aleksandra Niedzwiecki, Henderson, NV (US); Matthias W Rath, Henderson, NV (US); Vadim Ivanov, Castro Valley, CA (US); and Waldemar Sumera, Sanjose, CA (US)
Assigned to Matthias W. Rath, Henderson, NV (US)
Filed by Matthias W Rath, Henderson, NV (US)
Filed on Nov. 28, 2022, as Appl. No. 17/994,896.
Application 17/994,896 is a continuation in part of application No. 17/579,563, filed on Jan. 19, 2022, granted, now 11,571,468.
This patent is subject to a terminal disclaimer.
Int. Cl. A23L 33/15 (2016.01); A23L 33/105 (2016.01); A23L 33/175 (2016.01)
CPC A23L 33/15 (2016.08) [A23L 33/105 (2016.08); A23L 33/175 (2016.08)] 7 Claims
 
1. A method of relaxing a smooth muscle cell in a specific disease, wherein the specific disease is selected from at least one of bronchial disease and uterine disease, comprising:
administering a micronutrient composition comprised of a vitamin C in Calcium ascorbate or magnesium ascorbate form in the range of 0.01 mg-5000 mg, vitamin B1 in the range of 0.1 mg-50 mg, vitamin B2in the range of 0.1 mg-50 mg, vitamin B3 in the range of 1 mg-3000 mg, vitamin B6 in the range of 0.1 mg-50 mg, vitamin B12 in the range of 10 μg-300 μg, folate in the range of 10 μg-1000 μg, vitamin D in the range of 10 μg-400 μg, magnesium in the range of 5 mg-2500 mg, celery extract in the range of 10 mg-2000 mg, grape seed extract in the range of 10 mg-1000 mg, clove extract in the range of 10 mg-10000 mg, green tea extract in the range of 10 mg-1000 mg and L-arginine in the range of 10 mg-2000 mg in a mammal using a specific dose.